Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 1.00 |
| ▸ | P4HTM | Q9NXG6 | 10/20 | 0.38 |
| ▸ | P4HA1 | P13674 | 1/20 | 0.38 |
| ▸ | MIF | P14174 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.35 |
| ▸ | ASPH | Q12797 | 2/20 | 0.35 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acipimox SCHEMBL29370131 | 1.00 | HCAR2 (1.00) | HCAR2P4HTMP4HA1MIFKDM4E | |
| Acipimox SCHEMBL6057382 | 1.00 | HCAR2 (1.00) | HCAR2P4HTMP4HA1MIFKDM4E | |
| Acipimox SCHEMBL28690337 | 0.98 | HCAR2 (0.96) | HCAR2P4HTMP4HA1MIFKDM4E | |
| Acipimox SCHEMBL28681646 | 0.98 | HCAR2 (0.96) | HCAR2P4HTMP4HA1MIFKDM4E | |
| Acipimox SCHEMBL28986974 | 0.98 | HCAR2 (0.96) | HCAR2P4HTMP4HA1MIFKDM4E | |
| Acipimox SCHEMBL31290731 | 0.98 | HCAR2 (0.96) | HCAR2P4HTMP4HA1MIFKDM4E | |
| Acipimox SCHEMBL28273592 | 0.98 | HCAR2 (0.96) | HCAR2P4HTMP4HA1MIFKDM4E | |
| Acipimox SCHEMBL11743417 | 0.89 | HCAR2 (0.79) | HCAR2P4HTMP4HA1MIFKDM4E | |
| Acipimox SCHEMBL28438037 | 0.87 | HCAR2 (0.77) | HCAR2P4HTMP4HA1MIFKDM4E | |
| Acipimox SCHEMBL22409661 | 0.85 | HCAR2 (0.72) | HCAR2P4HTMKDM4EALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7760 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085061-A1 | PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS | SITRYX THERAPEUTICS LIMITED (GB) | 2026-03-26 | — | — | US | claimed |
| US-20260076956-A1 | METHODS FOR REGRESSING OR REVERSING FIBROSIS AND/OR LIVER CIRRHOSIS IN A SUBJECT IN NEED THEREOF USING HIGH-DOSE NIACIN, OR A NIACIN ANALOG THEREOF | US GOV VETERANS AFFAIRS (US) | 2026-03-19 | — | — | US | claimed |
| WO-2025264604-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | PROCTER & GAMBLE (US) | 2025-12-18 | — | — | US | claimed |
| EP-4612132-A1 | PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS | Sitryx Therapeutics Limited (GB) | 2025-09-10 | — | — | EP | claimed |
| EP-4583916-A2 | COMPOSITIONS AND METHODS FOR AMELIORATION OF SYMPTOMS ASSOCIATED WITH CLEC16A DYSFUNCTION OR LOSS | The Children's Hospital Of Philadelphia (US) | 2025-07-16 | — | — | EP | claimed |
| CN-120166987-A | Phthalazine derivatives as pyruvate kinase modulators | 西特瑞治疗有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-120114405-A | Acipimox capsule and preparation method thereof | 鲁南贝特制药有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-120037248-A | Medicament for simultaneously reducing bleeding and microvascular obstruction risks | 中国科学院上海药物研究所 | 2025-05-27 | — | — | CN | claimed |
| US-12280047-B2 | Treatment of aneurysms | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2025-04-22 | — | — | US | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2001000184-A2 | COMBINATION OF MTP INHIBITORS AND LIPID REDUCERS AND THE USE THEREOF IN MEDICAMENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-01-04 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| WO-2000038729-A1 | COMBINATIONS OF ILEAL BILE ACID TRANSPORT INHIBITORS AND NICOTINIC ACID DERIVATIVES FOR CARDIOVASCULAR INDICATIONS | G.D. SEARLE LLC (US) | 2000-07-06 | — | — | WO | claimed |
| WO-2000038721-A1 | COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND NICOTINIC ACID DERIVATIVES FOR CARDIOVASCULAR INDICATIONS | G.D. SEARLE LLC (US) | 2000-07-06 | — | — | WO | claimed |
| WO-1998022114-A1 | A METHOD FOR PROMOTING TISSUE REPAIR | DUMEX-ALPHARMA A/S (DK) | 1998-05-28 | — | — | WO | claimed |
| US-5668117-A | NERVOUS SYSTEM DISORDERS USING AROMATIC ACID COMPOUNDS | SECANT PHARMA, LLC | 1997-09-16 | — | — | US | claimed |
| US-5260305-A | Combination of pravastatin and nicotinic acid or related acid and method for lowering serum cholesterol using such combination | E. R. SQUIBB & SONS, INC. (US) | 1993-11-09 | — | — | US | claimed |
| US-5179097-A | Salts of non-steroidal anti-inflammatory carboxylic acids and anti-lipidemic carboxylic acids | ANGRES ISAAC A (US) | 1993-01-12 | — | — | US | claimed |
| US-4002750-A | HYPOGLYCEMIC AND HYPOLIPEMIC AGENTS | CARLO ERBA S.P.A. (IT) | 1977-01-11 | — | — | US | claimed |